Detalhe da pesquisa
1.
The value of bispecific antibodies in relapsed and refractory DLBCL.
Leuk Lymphoma
; 65(6): 720-735, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38454535
2.
Enrichment of BTK Leu528Trp mutations in patients with CLL on zanubrutinib: potential for pirtobrutinib cross-resistance.
Blood Adv
; 6(20): 5589-5592, 2022 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35901282
3.
About time: why central nervous system prophylaxis timing in diffuse large B-cell lymphoma matters and does the protocol need updating?
Expert Rev Hematol
; 15(11): 959-962, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36278876